Your browser doesn't support javascript.
loading
Empagliflozin improves renal ischemia-reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK-OPA1 pathway promotion.
Yang, Wenbo; Li, Xiaoli; He, Liujie; Zhu, Shuyang; Lai, Shicong; Zhang, Xiaopeng; Huang, Zixiong; Yu, Biyue; Cui, Chunping; Wang, Qiang.
Affiliation
  • Yang W; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
  • Li X; Department of the Eighth Healthcare, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
  • He L; Naval Medical University, Shanghai, 200433, China.
  • Zhu S; Naval Medical University, Shanghai, 200433, China.
  • Lai S; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
  • Zhang X; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
  • Huang Z; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
  • Yu B; School of Life Sciences, Hebei University, Baoding, 071002, Hebei, China.
  • Cui C; State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 100850, China.
  • Wang Q; Department of Urology, Peking University People's Hospital, Beijing, 100044, China. wq301135@126.com.
Cell Mol Biol Lett ; 28(1): 42, 2023 May 18.
Article in En | MEDLINE | ID: mdl-37202752

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Reperfusion Injury / Mitochondrial Dynamics Limits: Animals / Humans Language: En Journal: Cell Mol Biol Lett Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Reperfusion Injury / Mitochondrial Dynamics Limits: Animals / Humans Language: En Journal: Cell Mol Biol Lett Year: 2023 Document type: Article